Page 2 of 2 Previous
Gupte said the research could potentially turn into a moneymaker, if the results could be sold to insurance companies, the government or even health care systems that are being forced to take more financial responsibility for reducing readmissions under health reform efforts.
“If they can mine that information that resides not only in Optum’s legacy platform with the Humedica asset and then tie in with Mayo’s clinical capabilities, they could have some very meaningful insights into health care cost and quality and outcomes in various disease states, and with various drugs that might be playing into it from a therapeutic perspective. There’s a lot they could do.”
UnitedHealth, which operates the nation’s largest insurance company, is providing most of the claims data. The Mayo Clinic is supplying about 5 million patient records, but Optum Labs continues to collect data from hospital systems around the country.
Optum Labs’ Bleicher said the goal isn’t just to “do research and write papers,” but to improve the nation’s health and make fundamental changes in medical spending.
“It’s about creating a change in the system based upon this … and making sure the best of those changes actually gets widely distributed and used.”
Jackie Crosby • 612-673-7335